Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

Overview

Journal World J Mens Health

Date 2023 Oct 19

PMID 37853538

Authors

Lara Rodriguez-Sanchez

Mark Emberton

Theo de Reijke

Phillip Stricker

Bernardino Minana

Fernando Bianco

Jose Luis Dominguez Escrig

Anna Lantz

Rafael Sanchez-Salas

Affiliations

Soon will be listed here.

Citing Articles

The use of focal therapy for the treatment of prostate cancer in Canada Where are we, how did we get here, and where are we going?.

Kumar R, Ghai S, Finelli A, Klotz L, Kinnaird A, Mannas M Can Urol Assoc J. 2024; 19(2):63-72.

PMID: 39418491 PMC: 11819858. DOI: 10.5489/cuaj.8888.

References

Abreu A, Kaneko M, Cacciamani G, Lebastchi A . Focal Therapy for Prostate Cancer: Getting Ready for Prime Time. Eur Urol. 2021; 81(1):34-36. DOI: 10.1016/j.eururo.2021.10.005. View

Dickinson L, Ahmed H, Hindley R, McCartan N, Freeman A, Allen C . Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urol Oncol. 2016; 35(1):30.e9-30.e15. DOI: 10.1016/j.urolonc.2016.07.015. View

Reddy D, Peters M, Shah T, van Son M, Bertoncelli Tanaka M, Huber P . Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol. 2022; 81(4):407-413. DOI: 10.1016/j.eururo.2022.01.005. View

Czaja R, Tarima S, Wu R, Palagnmonthip W, Iczkowski K . Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. Ann Diagn Pathol. 2021; 52:151725. DOI: 10.1016/j.anndiagpath.2021.151725. View

Ferraro D, Hotker A, Becker A, Mebert I, Laudicella R, Baltensperger A . Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement. Eur J Hybrid Imaging. 2022; 6(1):14. PMC: 9288941. DOI: 10.1186/s41824-022-00135-4. View

Rodriguez Sanchez L, Macek P, Barbe Y, Cathelineau X, Sanchez-Salas R . Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. Eur Urol. 2020; 78(3):469-470. DOI: 10.1016/j.eururo.2020.04.022. View

Aslim E, Law Y, Fook-Chong S, Ho H, Yuen J, Lau W . Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?. BJU Int. 2021; 128(2):178-186. PMC: 8360156. DOI: 10.1111/bju.15355. View

de la Rosette J, Dominguez-Escrig J, Zhang K, Teoh J, Barret E, Casanova Ramon-Borja J . A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer. J Urol. 2022; 209(2):347-353. DOI: 10.1097/JU.0000000000003051. View

Azzouzi A, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel H . Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016; 18(2):181-191. DOI: 10.1016/S1470-2045(16)30661-1. View

10.

Lantz A, Nordlund P, Falagario U, Jaderling F, Ozbek O, Clements M . Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer. Eur Urol Open Sci. 2023; 51:89-94. PMC: 10114162. DOI: 10.1016/j.euros.2023.03.003. View

11.

Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I . Simultaneous Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. Eur Urol. 2016; 70(5):829-836. DOI: 10.1016/j.eururo.2015.12.053. View

12.

Stabile A, Sanchez-Salas R, Tourinho-Barbosa R, Macek P, Pellegrino F, Gandaglia G . Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy. J Urol. 2021; 206(3):638-645. DOI: 10.1097/JU.0000000000001787. View

13.

Blazevski A, Amin A, Scheltema M, Balakrishnan A, Haynes A, Barreto D . Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE). World J Urol. 2020; 39(4):1107-1114. DOI: 10.1007/s00345-020-03275-z. View

14.

Hofman M, Lawrentschuk N, Francis R, Tang C, Vela I, Thomas P . Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020; 395(10231):1208-1216. DOI: 10.1016/S0140-6736(20)30314-7. View

15.

Srougi V, Barret E, Nunes-Silva I, Baghdadi M, Garcia-Barreras S, Pierrat N . Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor location. Brachytherapy. 2017; 16(5):988-992. DOI: 10.1016/j.brachy.2017.05.009. View

16.

Lee A, Chen K, Tan Y, Lee H, Shutchaidat V, Fook-Chong S . Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis. 2022; 25(4):720-726. PMC: 9705237. DOI: 10.1038/s41391-021-00485-3. View

17.

Miszczyk M, Rembak-Szynkiewicz J, Magrowski L, Stawiski K, Namysl-Kaletka A, Napieralska A . The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer. Cancers (Basel). 2022; 14(7). PMC: 8997034. DOI: 10.3390/cancers14071613. View

18.

Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R . NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. J Natl Compr Canc Netw. 2022; 20(12):1288-1298. DOI: 10.6004/jnccn.2022.0063. View

19.

Ahmed H, El-Shater Bosaily A, Brown L, Gabe R, Kaplan R, Parmar M . Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815-822. DOI: 10.1016/S0140-6736(16)32401-1. View

20.

Howard J . Robotic, Laparoscopic, and Open Radical Prostatectomy-Is the Jury Still Out?. JAMA Netw Open. 2021; 4(8):e2120693. DOI: 10.1001/jamanetworkopen.2021.20693. View